Managers / Q3 2022 · view latest →
Bartlett & Co. LLC
CIK 0001550075 · 600 VINE STREET, SUITE 2100, CINCINNATI, OH, 45202 · (513) 621-4612
Summary
Bartlett & Co. LLC reported $4.7B in U.S.-listed holdings across 1,216 positions for Q3 2022.
Its largest position, AAPL, represents 5.5% of the portfolio.
Compared with Q2 2022, the fund opened 52 new positions and exited 168.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 76.1% · $3.5B
- ETP · 16.7% · $776M
- Other · 3.3% · $156M
- ADR · 1.6% · $75M
- REIT · 1.6% · $75M
- Other · 0.7% · $32M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| C T I Biopharma Corp | NEW | +37.0K | 37.0K | +$216,000 | $216,000 |
| KONGFormidable Fortress ETF | NEW | +7.1K | 7.1K | +$155,000 | $155,000 |
| TGTXTG Therapeutics Inc. | NEW | +25.0K | 25.0K | +$148,000 | $148,000 |
| BNTXBiontech Se F Unsponsored ADR | NEW | +650 | 650 | +$88,000 | $88,000 |
| JJacobs Solutions Inc | NEW | +800 | 800 | +$87,000 | $87,000 |
| Formidable ETF | NEW | +2.5K | 2.5K | +$56,000 | $56,000 |
| GSKGlaxo Wellcome PLC Spon ADR | NEW | +1.3K | 1.3K | +$39,000 | $39,000 |
| Liberty Media Corp Series A Liberty Braves | NEW | +1.2K | 1.2K | +$34,000 | $34,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2023 | $6.2B | 1,277 | Jan 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $5.6B | 1,213 | Oct 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $5.8B | 1,188 | Jul 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $5.2B | 1,085 | Apr 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $5.0B | 1,124 | Jan 4, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $4.7B | 1,216 | Oct 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $4.9B | 1,334 | Aug 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $5.7B | 1,086 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $5.2B | 946 | Oct 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $5.2B | 1,082 | Jul 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $5.0B | 1,114 | Apr 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $4.7B | 1,215 | Jan 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $4.3B | 851 | Oct 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $3.8B | 853 | Aug 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $3.3B | 852 | May 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $3.8B | 879 | Nov 4, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.7B | 770 | Jul 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.6B | 741 | Apr 23, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $2.3B | 703 | Jan 23, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.